ALTHE Theraclion SA

EPA · FR · Healthcare · Medical Devices · theraclion.com

0.6580EUR-0.60%Mkt Cap: 52.77M $P/E: —Today

Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive …

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap52.77M USD

Enterprise Value—

Revenue (TTM)521.74K USD

Gross Profit-3.10M USD

Net Income (TTM)-6.18M USD

Revenue/Share0.01 EUR

Last Price0.6580 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees40

CountryFR

SectorHealthcare

IndustryMedical Devices

ISINFR0010120402

Valuation

P/E (Trailing)—

P/E (Forward)6.62

PEG—

EV/EBITDA—

EV/Revenue—

P/S101.76

P/B-15.40

EPS (TTM)-0.09

EPS (Forward)0.10

52W Range

0.402048% of range0.9300

52W High0.9300 EUR

52W Low0.4020 EUR

Profitability

Gross Margin-240.81%

Oper. Margin-591.54%

EBITDA Margin0.00%

Profit Margin-479.76%

ROE219.81%

ROA-38.21%

Growth

Revenue Growth-20.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-7.78M USD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity-1.91

Current Ratio—

Quick Ratio—

Book Value/Sh-0.04 EUR

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.73.78M

Float32.35M

Insiders67.76%

Institutions0.00%

Technical

SMA 500.6603 (-0.3%)

SMA 2000.6131 (+7.3%)

Beta0.42

S&P 52W Chg14.58%

Avg Vol (30d)103.47K

Avg Vol (10d)85.27K

Technical Indicators

RSI (14)46.0

MACD0.0053

MACD Signal0.0090

MACD Hist.-0.0037

BB Upper0.7408 EUR

BB Middle0.6862 EUR

BB Lower0.6316 EUR

BB Width15.91%

ATR (14)0.0375 EUR

Vol Ratio (20d)1.57x